APA (7th ed.) Citation

Gaudet, D., Gonciarz, M., Shen, X., Mullins, G., Leohr, J., Benichou, O., . . . Ruotolo, G. (2022). A first-in-human single ascending dose study of a monoclonal antibody against the ANGPTL3/8 complex in subjects with mixed hyperlipidemia. Atherosclerosis, 355, 12. https://doi.org/10.1016/j.atherosclerosis.2022.06.034

Chicago Style (17th ed.) Citation

Gaudet, D., M. Gonciarz, X. Shen, G. Mullins, J.K Leohr, O. Benichou, T. Beyer, and G. Ruotolo. "A First-in-human Single Ascending Dose Study of a Monoclonal Antibody Against the ANGPTL3/8 Complex in Subjects with Mixed Hyperlipidemia." Atherosclerosis 355 (2022): 12. https://doi.org/10.1016/j.atherosclerosis.2022.06.034.

MLA (9th ed.) Citation

Gaudet, D., et al. "A First-in-human Single Ascending Dose Study of a Monoclonal Antibody Against the ANGPTL3/8 Complex in Subjects with Mixed Hyperlipidemia." Atherosclerosis, vol. 355, 2022, p. 12, https://doi.org/10.1016/j.atherosclerosis.2022.06.034.